Clinical Trial Update: Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating TAK-448 in men with prostate cancer was terminated; the trial assessed safety, pharmacokinetics, and testosterone-lowering efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TAK-448

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Prostate Cancer, Prostatic Neoplasms | Phase 1, Phase 2 | Status: TERMINATED